Atlas Trials

Forecasting Occult liveR Metastasis Using an Exosomal Signature for Intelligent Guided Hepatic Targeting

Clinical trial NCT07224802 · COMPLETED

Trial details

NCT number
NCT07224802
Sponsor
City of Hope Medical Center
Status
COMPLETED
Study type
OBSERVATIONAL
PDAC - Pancreatic Ductal Adenocarcinoma
Start date
2024-06-21
Primary completion
2026-01-18
Enrollment
372

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.